{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:22:32Z","timestamp":1791264152580,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vaxxinity, Dallas Tx, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alpha synuclein has a key role in the pathogenesis of Parkinson\u2019s disease (PD), Dementia with Lewy Bodies (LBD) and Multiple System Atrophy (MSA). Immunotherapies aiming at neutralising toxic \u03b1Syn species are being investigated in the clinic as potential disease modifying therapies for PD and other synucleinopathies. In this study, the effects of active immunisation against \u03b1Syn with the UB-312 vaccine were investigated in the Thy1SNCA\/15 mouse model of PD. Young transgenic and wild-type mice received an immunisation regimen over a period of 6\u00a0weeks, then observed for an additional 9\u00a0weeks. Behavioural assessment was conducted before immunisation and at 15\u00a0weeks after the first dose. UB-312 immunisation prevented the development of motor impairment in the wire test and challenging beam test, which was associated with reduced levels of \u03b1Syn oligomers in the cerebral cortex, hippocampus and striatum of Thy1SNCA\/15 mice. UB-312 immunotherapy resulted in a significant reduction of the\u03b1Syn load in the colon, accompanied by a reduction in enteric glial cell reactivity in the colonic ganglia. Our results demonstrate that immunisation with UB-312 prevents functional deficits and both central and peripheral pathology in Thy1SNCA\/15 mice.<\/jats:p>","DOI":"10.1007\/s00401-021-02381-5","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T06:03:42Z","timestamp":1636178622000},"page":"55-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric \u03b1-synuclein accumulation in the brain and gut"],"prefix":"10.1007","volume":"143","author":[{"given":"Jacqui T.","family":"Nimmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Teeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A. R.","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Cosme","family":"Dodart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6458-3776","authenticated-orcid":false,"given":"Roxana O.","family":"Carare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,6]]},"reference":[{"key":"2381_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-00954-8","volume":"10","author":"J Amin","year":"2020","unstructured":"Amin J, Holmes C, Dorey RB, Tommasino E, Casal YR, Williams DM et al (2020) Neuroinflammation in dementia with Lewy bodies: a human post-mortem study. Transl Psychiatry 10:1\u201311. https:\/\/doi.org\/10.1038\/s41398-020-00954-8","journal-title":"Transl Psychiatry"},{"key":"2381_CR2","doi-asserted-by":"publisher","first-page":"13454","DOI":"10.1523\/jneurosci.1292-12.2012","volume":"32","author":"EJ Bae","year":"2012","unstructured":"Bae EJ, Lee HJ, Rockenstein E, Ho DH, Park EB, Yang NY et al (2012) Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission. J Neurosci 32:13454\u201313469. https:\/\/doi.org\/10.1523\/jneurosci.1292-12.2012","journal-title":"J Neurosci"},{"key":"2381_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","volume":"13","author":"LD Bernal-Conde","year":"2020","unstructured":"Bernal-Conde LD, Ramos-Acevedo R, Reyes-Hern\u00e1ndez MA, Balbuena-Olvera AJ, Morales-Moreno ID, Arg\u00fcero-S\u00e1nchez R et al (2020) Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles. Front Neurosci 13:1399. https:\/\/doi.org\/10.3389\/fnins.2019.01399","journal-title":"Front Neurosci"},{"key":"2381_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/glia.22746","volume":"63","author":"W Boesmans","year":"2015","unstructured":"Boesmans W, Lasrado R, Vanden Berghe P, Pachnis V (2015) Heterogeneity and phenotypic plasticity of glial cells in the mammalian enteric nervous system. Glia 63:229\u2013241. https:\/\/doi.org\/10.1002\/glia.22746","journal-title":"Glia"},{"key":"2381_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114:231\u2013241. https:\/\/doi.org\/10.1007\/s00401-007-0244-3","journal-title":"Acta Neuropathol"},{"key":"2381_CR6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.90.15_supplement.S26.001","volume":"90","author":"M Brys","year":"2018","unstructured":"Brys M, Ellenbogen A, Fanning L, Penner N, Yang M, Welch M et al (2018) Randomized, double-blind, placebo-controlled, single ascending dose study of anti-alpha-synuclein antibody BIIB054 in patients with Parkinson\u2019s disease (S26.001). Neurology 90:1154\u20131163","journal-title":"Neurology"},{"key":"2381_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapy 9:297\u2013314. https:\/\/doi.org\/10.1007\/s13311-012-0104-2","journal-title":"Neurotherapy"},{"key":"2381_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15119-w","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K et al (2020) Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-15119-w","journal-title":"Nat Commun"},{"key":"2381_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jnc.12742","volume":"130","author":"T Clairembault","year":"2014","unstructured":"Clairembault T, Kamphuis W, Leclair-Visonneau L, Rolli-Derkinderen M, Coron E, Neunlist M et al (2014) Enteric GFAP expression and phosphorylation in Parkinson\u2019s disease. J Neurochem 130:805\u2013815. https:\/\/doi.org\/10.1111\/jnc.12742","journal-title":"J Neurochem"},{"key":"2381_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L et al (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. https:\/\/doi.org\/10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"key":"2381_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.06.020","author":"LM De Biase","year":"2017","unstructured":"De Biase LM, Schuebel KE, Fusfeld ZH, Jair K, Hawes IA, Cimbro R et al (2017) Local cues establish and maintain region-specific phenotypes of basal ganglia microglia. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2017.06.020","journal-title":"Neuron"},{"key":"2381_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14806","author":"M Delenclos","year":"2019","unstructured":"Delenclos M, Burgess JD, Lamprokostopoulou A, Outeiro TF, Vekrellis K, McLean PJ (2019) Cellular models of alpha-synuclein toxicity and aggregation. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.14806","journal-title":"J Neurochem"},{"key":"2381_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.09.007","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H et al (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2012.09.007","journal-title":"Neurobiol Dis"},{"key":"2381_CR14","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"HB Dodiya","year":"2020","unstructured":"Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M et al (2020) Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis 135:104352. https:\/\/doi.org\/10.1016\/j.nbd.2018.12.012","journal-title":"Neurobiol Dis"},{"key":"2381_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ene.13919","volume":"26","author":"R Durcan","year":"2019","unstructured":"Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW et al (2019) Prevalence and duration of non-motor symptoms in prodromal Parkinson\u2019s disease. Eur J Neurol 26:979\u2013985. https:\/\/doi.org\/10.1111\/ene.13919","journal-title":"Eur J Neurol"},{"key":"2381_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022225","volume":"6","author":"E Emmanouilidou","year":"2011","unstructured":"Emmanouilidou E, Elenis D, Papasilekas T, Stranjalis G, Gerozissis K, Ioannou PC et al (2011) Assessment of alpha-synuclein secretion in mouse and human brain parenchyma. PLoS ONE 6:e22225. https:\/\/doi.org\/10.1371\/journal.pone.0022225","journal-title":"PLoS ONE"},{"key":"2381_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14:625\u2013639. https:\/\/doi.org\/10.1016\/S1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"key":"2381_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247. https:\/\/doi.org\/10.3389\/fncel.2018.00247","journal-title":"Front Cell Neurosci"},{"key":"2381_CR19","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/jneurosci.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS et al (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24:9434\u20139440. https:\/\/doi.org\/10.1523\/jneurosci.3080-04.2004","journal-title":"J Neurosci"},{"key":"2381_CR20","unstructured":"Flurkey, Currer, Harrison (2007) The mouse in biomedical research. American College of Laboratory Animal Medicine series, vol 3, 2nd edn. Elsevier, Amsterdam, Boston"},{"key":"2381_CR21","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"L He-Jin","year":"2005","unstructured":"He-Jin L, Smita P, Seung-Jae L (2005) Intravesicular localization and exocytosis of \u03b1-synuclein and its aggregates. J Neurosci 25:6016\u20136024. https:\/\/doi.org\/10.1523\/JNEUROSCI.0692-05.2005","journal-title":"J Neurosci"},{"key":"2381_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1214-6","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J et al (2014) Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol Commun. https:\/\/doi.org\/10.1007\/s00401-013-1214-6","journal-title":"Acta Neuropathol Commun"},{"key":"2381_CR23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","author":"WG Kim","year":"2000","unstructured":"Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-16-06309.2000","journal-title":"J Neurosci"},{"key":"2381_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-w","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151\u2013170. https:\/\/doi.org\/10.1016\/0306-4522(90)90229-w","journal-title":"Neuroscience"},{"key":"2381_CR25","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S et al (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272. https:\/\/doi.org\/10.1074\/jbc.M109.081125","journal-title":"J Biol Chem"},{"key":"2381_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14802\/jmd.15059","volume":"9","author":"JS Lee","year":"2016","unstructured":"Lee JS, Lee SJ (2016) Mechanism of anti-\u03b1-synuclein immunotherapy. J Mov Disorder 9:14\u201319. https:\/\/doi.org\/10.14802\/jmd.15059","journal-title":"J Mov Disorder"},{"key":"2381_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","volume":"135","author":"A Lionnet","year":"2017","unstructured":"Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH et al (2017) Does Parkinson\u2019s disease start in the gut? Acta Neuropathol 135:1\u201312. https:\/\/doi.org\/10.1007\/s00401-017-1777-8","journal-title":"Acta Neuropathol"},{"key":"2381_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-014-1256-4","volume":"127","author":"M Mandler","year":"2014","unstructured":"Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, Adame A et al (2014) Next-generation active immunization approach for synucleinopathies: implications for Parkinson\u2019s disease clinical trials. Acta Neuropathol 127:861\u2013879. https:\/\/doi.org\/10.1007\/s00401-014-1256-4","journal-title":"Acta Neuropathol"},{"key":"2381_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M et al (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868. https:\/\/doi.org\/10.1016\/j.neuron.2005.05.010","journal-title":"Neuron"},{"key":"2381_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan EC, Wessels AM, Ardayfio PA, Andersen SW et al (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"},{"key":"2381_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW (2014) Regional specialization within the intestinal immune system. Nat Rev Immunol 14:667\u2013685. https:\/\/doi.org\/10.1038\/nri3738","journal-title":"Nat Rev Immunol"},{"key":"2381_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019172","author":"S Mukhtar","year":"2018","unstructured":"Mukhtar S, Imran R, Zaheer M, Tariq H (2018) Frequency of non-motor symptoms in Parkinson\u2019s disease presenting to tertiary care centre in Pakistan: an observational, cross-sectional study. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2017-019172","journal-title":"BMJ Open"},{"key":"2381_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448\u2013452. https:\/\/doi.org\/10.1038\/nm840","journal-title":"Nat Med"},{"key":"2381_CR34","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314\u20131318. https:\/\/doi.org\/10.1126\/science.1110647","journal-title":"Science"},{"key":"2381_CR35","doi-asserted-by":"publisher","first-page":"733857","DOI":"10.3389\/fnins.2021.733857","volume":"15","author":"JT Nimmo","year":"2021","unstructured":"Nimmo JT, Kelly L, Verma A, Carare RO, Nicoll JAR, Dodart J-C (2021) Amyloid-\u03b2 and \u03b1-synuclein immunotherapy: from experimental studies to clinical trials. Front Neurosci 15:733857. https:\/\/doi.org\/10.3389\/fnins.2021.733857","journal-title":"Front Neurosci"},{"key":"2381_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13195-020-00727-x","volume":"12","author":"JT Nimmo","year":"2020","unstructured":"Nimmo JT, Verma A, Dodart JC, Wang CY, Savistchenko J, Melki R et al (2020) Novel antibodies detect additional \u03b1-synuclein pathology in synucleinopathies: potential development for immunotherapy. Alzheimers Res Ther 12:159. https:\/\/doi.org\/10.1186\/s13195-020-00727-x","journal-title":"Alzheimers Res Ther"},{"key":"2381_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ et al (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893\u2013901. https:\/\/doi.org\/10.1002\/ana.23687","journal-title":"Ann Neurol"},{"key":"2381_CR38","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/mds.26979","volume":"32","author":"CH Nykjaer","year":"2017","unstructured":"Nykjaer CH, Brudek T, Salvesen L, Pakkenberg B (2017) Changes in the cell population in brain white matter in multiple system atrophy. Mov Disord 32:1074\u20131082. https:\/\/doi.org\/10.1002\/mds.26979","journal-title":"Mov Disord"},{"key":"2381_CR39","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM (2005) A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease. Brain 128:2665\u20132674. https:\/\/doi.org\/10.1093\/brain\/awh625","journal-title":"Brain"},{"key":"2381_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D et al (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:5. https:\/\/doi.org\/10.1186\/s13024-019-0306-8","journal-title":"Mol Neurodegener"},{"key":"2381_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24526","volume":"6","author":"L Pieri","year":"2016","unstructured":"Pieri L, Madiona K, Melki R (2016) Structural and functional properties of prefibrillar \u03b1-synuclein oligomers. Sci Rep 6:1\u201315. https:\/\/doi.org\/10.1038\/srep24526","journal-title":"Sci Rep"},{"key":"2381_CR42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622\u2013634. https:\/\/doi.org\/10.1038\/nrneurol.2016.152","journal-title":"Nat Rev Neurol"},{"key":"2381_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman SJ, Haupt HM, Yang P, Hamilton S (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson\u2019s disease. Gastroenterology 87:848\u2013856","journal-title":"Gastroenterology"},{"key":"2381_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12868-017-0341-8","volume":"18","author":"R Rabl","year":"2017","unstructured":"Rabl R, Breitschaedel C, Flunkert S, Duller S, Amschl D, Neddens J et al (2017) Early start of progressive motor deficits in line 61 alpha-synuclein transgenic mice. BMC Neurosci 18:22. https:\/\/doi.org\/10.1186\/s12868-017-0341-8","journal-title":"BMC Neurosci"},{"key":"2381_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/cercor\/bhv228","volume":"27","author":"L Salvesen","year":"2017","unstructured":"Salvesen L, Winge K, Brudek T, Agander TK, L\u00f8kkegaard A, Pakkenberg B (2017) Neocortical neuronal loss in patients with multiple system atrophy: a stereological study. Cereb Cortex 27:400\u2013410. https:\/\/doi.org\/10.1093\/cercor\/bhv228","journal-title":"Cereb Cortex"},{"key":"2381_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70287-X","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I (2015) Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(14)70287-X","journal-title":"Lancet Neurol"},{"key":"2381_CR47","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.19057","author":"J Shin","year":"2020","unstructured":"Shin J, Kim HJ, Jeon B (2020) Immunotherapy targeting neurodegenerative proteinopathies: \u03b1-synucleinopathies and tauopathies. J Mov Disord. https:\/\/doi.org\/10.14802\/jmd.19057","journal-title":"J Mov Disord"},{"key":"2381_CR48","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/NEN.0b013e3181b66f1b","volume":"68","author":"YJ Song","year":"2009","unstructured":"Song YJ, Halliday GM, Holton JL, Lashley T, O\u2019Sullivan SS, McCann H et al (2009) Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 68:1073\u20131083. https:\/\/doi.org\/10.1097\/NEN.0b013e3181b66f1b","journal-title":"J Neuropathol Exp Neurol"},{"key":"2381_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-01977-2","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Giasson BI, Chakrabarty P (2019) alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-01977-2","journal-title":"Acta Neuropathol"},{"key":"2381_CR50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J","volume":"33","author":"N Stence","year":"2001","unstructured":"Stence N, Waite M, Dailey ME (2001) Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33:256\u2013266","journal-title":"Glia"},{"issue":"Suppl","key":"2381_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mds.22719","volume":"25","author":"M Stern","year":"2010","unstructured":"Stern M, Siderowf A (2010) Parkinson\u2019s at risk syndrome: can Parkinson\u2019s disease be predicted? Mov Disord 25(Suppl):1. https:\/\/doi.org\/10.1002\/mds.22719","journal-title":"Mov Disord"},{"key":"2381_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P (2016) Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 79:940\u2013949. https:\/\/doi.org\/10.1002\/ana.24648","journal-title":"Ann Neurol"},{"key":"2381_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nbd.2015.06.010","volume":"82","author":"J Tong","year":"2015","unstructured":"Tong J, Ang L, Williams B, Furukawa Y, Fitzmaurice P, Guttman M et al (2015) Low levels of astroglial markers in Parkinson\u2019s disease: relationship to \u03b1-synuclein accumulation. Neurobiol Dis 82:243\u2013253. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.010","journal-title":"Neurobiol Dis"},{"issue":"Suppl","key":"2381_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03713.x","volume":"153","author":"G Vighi","year":"2008","unstructured":"Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F (2008) Allergy and the gastrointestinal system. Clin Exp Immunol 153(Suppl):1. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03713.x","journal-title":"Clin Exp Immunol"},{"key":"2381_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A et al (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"2381_CR56","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/ajpgi.00091.2002","volume":"283","author":"PR Wade","year":"2002","unstructured":"Wade PR (2002) Aging and neural control of the GI tract. Am J Physiol Gastrointest Liver Physiol 283:489\u2013495. https:\/\/doi.org\/10.1152\/ajpgi.00091.2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2381_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol 76:217\u2013221. https:\/\/doi.org\/10.1007\/BF00687767","journal-title":"Acta Neuropathol"},{"key":"2381_CR58","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.vaccine.2007.01.031","volume":"25","author":"C Wang","year":"2007","unstructured":"Wang C, Finstad C, Walfield A, Sia C, Sokoll K, Changa T et al (2007) Site-specific UBITh\u00ae amyloid-beta vaccine for immunotherapy of Alzheimer\u2019s disease. Vaccine 25:3041\u20133052","journal-title":"Vaccine"},{"key":"2381_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","volume":"3","author":"CY Wang","year":"2017","unstructured":"Wang CY, Wang PN, Chiu MJ, Finstad CL, Lin F, Lynn S et al (2017) UB-311, a novel UBITh(R) amyloid beta peptide vaccine for mild Alzheimer\u2019s disease. Alzheimers Dement 3:262\u2013272. https:\/\/doi.org\/10.1016\/j.trci.2017.03.005","journal-title":"Alzheimers Dement"},{"key":"2381_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01974.x","author":"L Wang","year":"2012","unstructured":"Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF et al (2012) Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterol Motil. https:\/\/doi.org\/10.1111\/j.1365-2982.2012.01974.x","journal-title":"Neurogastroenterol Motil"},{"key":"2381_CR61","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.1073\/pnas.1417883112","volume":"112","author":"S Wang","year":"2015","unstructured":"Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H et al (2015) \u03b1-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci USA 112:E1926\u2013E1935. https:\/\/doi.org\/10.1073\/pnas.1417883112","journal-title":"Proc Natl Acad Sci USA"},{"key":"2381_CR62","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202076","author":"CL West","year":"2020","unstructured":"West CL, Mao YK, Delungahawatta T, Amin JY, Farhin S, McQuade RM et al (2020) Squalamine restores the function of the enteric nervous system in mouse models of parkinson\u2019s disease. J Parkinsons Dis. https:\/\/doi.org\/10.3233\/JPD-202076","journal-title":"J Parkinsons Dis"},{"key":"2381_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011337","volume":"97","author":"F Yan","year":"2018","unstructured":"Yan F, Chen Y, Li M, Wang Y, Zhang W, Chen X et al (2018) Gastrointestinal nervous system \u03b1-synuclein as a potential biomarker of Parkinson disease. Medicine 97:e11337. https:\/\/doi.org\/10.1097\/MD.0000000000011337","journal-title":"Medicine"},{"key":"2381_CR64","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00429-012-0446-x","volume":"218","author":"TT Yang","year":"2013","unstructured":"Yang TT, Lin C, Hsu CT, Wang TF, Ke FY, Kuo YM (2013) Differential distribution and activation of microglia in the brain of male C57BL\/6J mice. Brain Struct Funct 218:1051\u20131060. https:\/\/doi.org\/10.1007\/s00429-012-0446-x","journal-title":"Brain Struct Funct"},{"key":"2381_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16790-8","author":"QJ Yu","year":"2018","unstructured":"Yu QJ, Yu SY, Zuo LJ, Lian T, Hu Y, Wang RD et al (2018) Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-16790-8","journal-title":"Sci Rep"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02381-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-021-02381-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-021-02381-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T12:54:49Z","timestamp":1726059289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-021-02381-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,6]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2381"],"URL":"https:\/\/doi.org\/10.1007\/s00401-021-02381-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,6]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AV, J-CD and CYW are or have been employed by Vaxxinity. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}